• Like
  • Comment
  • Favorite

Zylox-Tonbridge Medical Swings to Profit in 2024 as Revenue Jumps 48%

MT Newswires Live03-21

Zylox-Tonbridge Medical Technology (HKG:2190) reported a profit attributable to shareholders of 100.3 million yuan for 2024, rebounding from a loss of 78.7 million yuan in the previous year.

Earnings per share were 0.3057 yuan, according to a Thursday filing with the Hong Kong bourse.

Revenue for the year rose 48% to 782.5 million yuan from 527.8 million yuan in the prior year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

empty
No comments yet
errorbox banner

抱歉,当前请求异常(-1)

7x24

  • 14:37

    Lutnick: Tariffs Going to Stay in Place for Days and Weeks -Cbs News

  • 14:37

    U.S. Commerce Secretary Howard Lutnick: There's No Postponing Tariffs -Cbs News Interview

  • 13:58

    EU's Von Der Leyen Says Will Meet UK's Starmer in London on April 24

  • 13:58

    EU's Von Der Leyen Says Committed to Working With UK on Security, Defence, Support for Ukraine, Says Russia Stalling Peace Efforts

  • 13:58

    EU's Von Der Leyen Says Determined to Work With Partners to Respond to New Reality in Global Economy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial